NCT01222481

Brief Summary

Cancer survivorship has dramatically improved within the last four decades and a greater number of Americans are living after cancer diagnosis. An increase in the number of survivors has highlighted the need to investigate the quality of life experienced by these survivors. While Survivorship research has improved our understanding of the challenges faced by some cancer survivors, there is a paucity of research on the functional and cognitive health status of head and neck cancer survivors. The purpose of this study is to evaluate the functional and cognitive changes that occur in head and neck cancer patients as a result of cancer treatment, in an attempt to increase our understanding of the complex interactions between cancer treatment, comorbid health ailments and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2009

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 15, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 18, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

March 2, 2012

Status Verified

February 1, 2012

Enrollment Period

2.6 years

First QC Date

October 15, 2010

Last Update Submit

February 29, 2012

Conditions

Keywords

Head and Neck CancerFunctional StatusCognitive StatusNeurocognitive AssessmentsPerformance-based AssessmentsCancerFunctionCognitionQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Functional and Cognitive health status

    At the time of cancer diagnosis and Within 1 month of cancer therapy

Secondary Outcomes (1)

  • Assess the effectiveness of novel performance-based tests in detecting subtle functional and cognitive health status changes

    At the time of cancer diagnosis and Within 1 month of cancer therapy

Study Arms (1)

Newly-diagnosed Head and Neck Cancer

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the Washington University Physicians Faculty Practice clinics of Adult Otolaryngology, Medical Oncology and Radiation Oncology

You may qualify if:

  • Subjects must be 40 years of age or older.
  • Subjects must be able to read, write and speak English fluently.
  • Subjects must be newly diagnosed with head and neck squamous cell cancer.
  • Subjects must not have already had treatment for this cancer diagnosis.
  • Subjects must be anticipated to receive at least one of the following types of therapy: surgery, chemotherapy or radiation.

You may not qualify if:

  • Subjects with prior cancer diagnoses who have evidence of active disease.
  • Subjects who have received cancer treatment within the past year.
  • Subjects who have received chemotherapy or radiation treatment within the past year (for any disease state).
  • Life expectancy of less than 3 months.
  • Subjects with melanoma or other non-squamous cell cancer.
  • Subjects who score \>9 on Short Blessed Test (SBT) at baseline.
  • Subjects who are unable to complete all of the required forms and tasks at baseline, either because of cognitive deficits or physical limitations.
  • Any medical condition the PI determines to affect safe study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site

Study Officials

  • Oluwafunmilola T Okuyemi, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Jay F Piccirillo, MD, FACS

    Washington University School of Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, Washington University School of Medicine

Study Record Dates

First Submitted

October 15, 2010

First Posted

October 18, 2010

Study Start

July 1, 2009

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

March 2, 2012

Record last verified: 2012-02

Locations